• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    10/19/23 1:52:24 PM ET
    $AHG
    $ALPP
    $BCEL
    $BEAM
    Real Estate
    Real Estate
    Telecommunications Equipment
    Telecommunications
    Get the next $AHG alert in real time by email

    Gainers

    • SeaStar Medical Holding Corporation (NASDAQ:ICU) shares climbed 36.4% to $1.0516. SeaStar medical shares jumped 70% on Wednesday after the FDA granted the company's Selective Cytopheretic Device Breakthrough Device Designation for hepatorenal syndrome.
    • Outlook Therapeutics, Inc. (NASDAQ:OTLK) jumped 33.6% to $0.6304.
    • MMTec, Inc. (NASDAQ:MTC) rose 32% to $1.7929.
    • Atreca, Inc. (NASDAQ:BCEL) shares gained 28.8% to $0.3490. On Sept. 21, Atreca announced the termination of the lease at its corporate headquarters and the departure of the company's CFO.
    • Spectral AI, Inc. (NASDAQ:MDAI) gained 26.7% to $3.2803. Spectral AI said that its DeepView SnapShot® Wound Imaging System is now UK Conformity Assessed (UKCA)-marked for use in the United Kingdom and has received Class 1 medical device classification with the United States Food and Drug Administration (FDA).
    • Alpine 4 Holdings, Inc. (NASDAQ:ALPP) surged 25% to $1.0999.
    • Maison Solutions Inc. (NASDAQ:MSS) surged 24.7% to $8.13.
    • Biocept, Inc. (NASDAQ:BIOC) gained 23.3% to $0.6780.
    • HUB Cyber Security Ltd. (NASDAQ:HUBC) rose 22.7% to $0.56.
    • SAB Biotherapeutics, Inc. (NASDAQ:SABS) climbed 22.4% to $0.7592 after the company announced it received Australian approval to commence the Phase 1 clinical trial of SAB-142.
    • Mangoceuticals, Inc. (NASDAQ:MGRX) rose 19.6% to $0.80. Mangoceuticals, Inc. issued an update to shareholders on third-quarter achievements and guidance on year end and near-term initiatives.
    • PTC Therapeutics, Inc. (NASDAQ:PTCT) jumped 18.6% to $24.31. PTC Therapeutics announced an agreement with Royalty Pharma to monetize up to $1.5 billion of the Evrysdi Royalty Stream.
    • Lindsay Corporation (NYSE:LNN) climbed 17.6% to $125.68 following better-than-expected fourth-quarter results.
    • G1 Therapeutics, Inc. (NASDAQ:GTHX) gained 16.6% to $1.5050.
    • Netflix, Inc. (NASDAQ:NFLX) shares jumped 16.5% to $403.38 after the company reported better-than-expected results for its third quarter. The company said it sees fourth-quarter revenue of $8.692 million versus estimates of $8.77 billion. Fourth-quarter earnings are expected to come in at $2.15 per share, in line with analyst expectations.
    • Chijet Motor Company, Inc. (NASDAQ:CJET) gained 16.3% to $2.65.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) jumped 15% to $0.29.
    • Heritage Financial Corporation (NASDAQ:HFWA) surged 9.6% to $17.88 after the company reported better-than-expected quarterly EPS results.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) climbed 9.5% to $14.81.
    • Nano Dimension Ltd. (NASDAQ:NNDM) gained 8.7% to $2.6950. Nano Dimension received Israeli Court approval for its $200 million repurchase plan.
    • AT&T Inc. (NYSE:T) gained 7.8% to $15.44 after the company reported better-than-expected third-quarter financial results.
    • Summit Materials, Inc. (NYSE:SUM) rose 7.6% to $34.19. The company filed preliminary M&A-related proxy statement.
    • Minerals Technologies Inc. (NYSE:MTX) rose 6.8% to $53.56. Sidoti & Co. upgraded Minerals Technologies from Neutral to Buy and announced a $65 price target.
    • Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) gained 6% to $33.63. Ultragenyx Pharmaceutical priced its $300 million underwritten public offering of 8,333,334 common shares at $30 per share.
    • SAP SE (NYSE:SAP) rose 5.5% to $134.62 after the company reported third-quarter financial results.
    • Union Pacific Corporation (NYSE:UNP) gained 4% to $214.00 following quarterly results.
    • Badger Meter, Inc. (NYSE:BMI) rose 3.9% to $139.99 following third-quarter results.

    Losers

    • Nxu, Inc. (NASDAQ:NXU) shares fell 36.8% to $0.0436 after the company announced a $3 million public offering of common stock of 86 million shares at $0.035 per share.
    • Perception Capital Corp. II (NASDAQ:PCCT) shares dipped 35.7% to $6.01.
    • RVL Pharmaceuticals plc (NASDAQ:RVLP) fell 32% to $0.0397.
    • Generation Bio Co. (NASDAQ:GBIO) fell 26.8% to $1.7650 after TD Cowen downgraded the stock from Outperform to Market Perform.
    • Grindrod Shipping Holdings Ltd. (NASDAQ:GRIN) fell 25.7% to $9.20.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) declined 25.7% to $1.29.
    • Gamer Pakistan Inc. (NASDAQ:GPAK) fell 25% to $1.08.
    • Nuvve Holding Corp. (NASDAQ:NVVE) fell 22.5% to $0.1549 after falling around 24% on Wednesday. Nuvve Holding reported pricing of $1 million underwritten public offering of 7,142,857 shares of common stock at a price of $0.14 per share.
    • Semtech Corporation (NASDAQ:SMTC) declined 22.3% to $15.47 after the company announced a $250 million private placement offering.
    • Micromobility.com Inc. (NASDAQ:MCOM) shares fell 19.8% to $0.0369 after gaining 11% on Wednesday.
    • Rentokil Initial plc (NYSE:RTO) shares fell 17.9% to $29.32. The company said it now sees North America’s annual adjusted operating margin in the range of 18.5% to 19%, versus its earlier forecast of around 19.5%.
    • WNS (Holdings) Limited (NYSE:WNS) declined 16.7% to $57.19 after the company reported mixed second-quarter financial results and updated FY24 guidance.
    • Akso Health Group (NASDAQ:AHG) fell 17.1% to $1.31.
    • Mullen Automotive, Inc. (NASDAQ:MULN) was fell 17.1% to $0.2856 after the company announced that it filed a preliminary proxy statement to the SEC to hold a stockholders' meeting to effect a reverse stock split.
    • Beam Therapeutics Inc. (NASDAQ:BEAM) fell 12.3% to $18.24 after the company announced portfolio prioritization and strategic restructuring.
    • Genuine Parts Company (NYSE:GPC) dropped 11.4% to $131.68 after the company reported worse-than-expected third-quarter revenue results and issued FY23 guidance.
    • VMware, Inc. (NYSE:VMW) shares declined 10.2% to $149.32 following an FT report suggesting China is weighing delaying approval of the company's Broadcom deal.
    • NuScale Power Corporation (NYSE:SMR) fell 10.1% to $4.5327.
    • WW International, Inc. (NASDAQ:WW) declined 9.6% to $10.56.
    • Tesla, Inc. (NASDAQ:TSLA) fell 9.4% to $219.91 as the company reported weaker-than-expected earnings and sales results for its third quarter. The company also said Cybertruck began pilot production in the third quarter at Gigafactory Texas, with deliveries anticipated for November 2023.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 9% to $1.57 after gaining over 6% on Wednesday.
    • Blue Star Foods Corp. (NASDAQ:BSFC) shares fell 9% to $0.1720 after falling over 4% on Wednesday.
    • Beyond Meat, Inc. (NASDAQ:BYND) dipped 8.8% to $7.43.
    • GDEV Inc. (NASDAQ:GDEV) fell 7.7% to $2.5120.
    • Nokia Oyj (NYSE:NOK) shares slipped 5.5% to $3.2050 after the company reported downbeat quarterly results. Nokia targets €0.8 billion - $1.2 billion gross cost savings by 2026, leading to a total company headcount of 72,000 - 77,000, down from the 86,000 employees Nokia has today.

     

    Now Read This: Top 3 Materials Stocks You May Want To Dump This Month

    Get the next $AHG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHG
    $ALPP
    $BCEL
    $BEAM

    CompanyDatePrice TargetRatingAnalyst
    Netflix Inc.
    $NFLX
    2/27/2026$115.00Outperform
    Evercore ISI
    NuScale Power Corporation
    $SMR
    2/27/2026$21.00Market Perform → Outperform
    Northland Capital
    Netflix Inc.
    $NFLX
    2/27/2026Neutral → Buy
    Arete
    Rentokil Initial plc
    $RTO
    2/24/2026Buy → Hold
    Deutsche Bank
    Genuine Parts Company
    $GPC
    2/24/2026$145.00Mkt Perform → Strong Buy
    Raymond James
    Beam Therapeutics Inc.
    $BEAM
    2/20/2026$74.00Buy
    Canaccord Genuity
    Genuine Parts Company
    $GPC
    2/18/2026$127.00Buy → Hold
    Truist
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    More analyst ratings

    $AHG
    $ALPP
    $BCEL
    $BEAM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wilson-Thompson Kathleen exercised 40,000 shares at a strike of $14.99 and sold $10,692,814 worth of shares (25,731 units at $415.56), increasing direct ownership by 264% to 19,669 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    2/27/26 7:00:21 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Sr. Exec VP and CFO Desroches Pascal gifted 352,000 shares and received a gift of 352,000 shares, decreasing direct ownership by 36% to 635,532 units (SEC Form 4)

    4 - AT&T INC. (0000732717) (Issuer)

    2/27/26 4:23:28 PM ET
    $T
    Telecommunications Equipment
    Telecommunications

    SEC Form 4 filed by President Mcdonald Bryan

    4 - HERITAGE FINANCIAL CORP /WA/ (0001046025) (Issuer)

    2/27/26 4:04:44 PM ET
    $HFWA
    Banks
    Finance

    $AHG
    $ALPP
    $BCEL
    $BEAM
    SEC Filings

    View All

    Ensysce Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)

    2/27/26 4:30:54 PM ET
    $ENSC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Netflix Inc.

    8-K - NETFLIX INC (0001065280) (Filer)

    2/27/26 3:15:18 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form 10-K filed by Heritage Financial Corporation

    10-K - HERITAGE FINANCIAL CORP /WA/ (0001046025) (Filer)

    2/27/26 2:11:03 PM ET
    $HFWA
    Banks
    Finance

    $AHG
    $ALPP
    $BCEL
    $BEAM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI resumed coverage on Netflix with a new price target

    Evercore ISI resumed coverage of Netflix with a rating of Outperform and set a new price target of $115.00

    2/27/26 8:31:30 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    NuScale Power upgraded by Northland Capital with a new price target

    Northland Capital upgraded NuScale Power from Market Perform to Outperform and set a new price target of $21.00

    2/27/26 8:22:27 AM ET
    $SMR
    Metal Fabrications
    Industrials

    Netflix upgraded by Arete

    Arete upgraded Netflix from Neutral to Buy

    2/27/26 8:22:06 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AHG
    $ALPP
    $BCEL
    $BEAM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for COSELA

    Submission status for G1 THERAPEUTICS INC's drug COSELA (ORIG-1) with active ingredient TRILACICLIB DIHYDROCHLORIDE has changed to 'Approval' on 02/12/2021. Application Category: NDA, Application Number: 214200, Application Classification: Type 1 - New Molecular Entity

    2/16/21 4:31:16 PM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for COSELA

    Submission status for G1 THERAPEUTICS INC's drug COSELA (ORIG-1) with active ingredient TRILACICLIB has changed to 'Approval' on 02/12/2021. Application Category: NDA, Application Number: 214200, Application Classification: Type 1 - New Molecular Entity

    2/16/21 11:21:53 AM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHG
    $ALPP
    $BCEL
    $BEAM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, President & CEO Bockhorst Kenneth bought $502,986 worth of shares (3,300 units at $152.42), increasing direct ownership by 9% to 40,013 units (SEC Form 4)

    4 - BADGER METER INC (0000009092) (Issuer)

    2/11/26 9:57:41 AM ET
    $BMI
    Industrial Machinery/Components
    Industrials

    EVP-N.A. Muncipal Utility Wrocklage Robert bought $251,378 worth of shares (1,650 units at $152.35), increasing direct ownership by 9% to 19,541 units (SEC Form 4)

    4 - BADGER METER INC (0000009092) (Issuer)

    2/10/26 9:38:13 AM ET
    $BMI
    Industrial Machinery/Components
    Industrials

    Amendment: VP-Global Operations Htwe Richard bought $501,153 worth of shares (3,370 units at $148.71), increasing direct ownership by 222% to 4,885 units (SEC Form 4)

    4/A - BADGER METER INC (0000009092) (Issuer)

    2/9/26 5:11:59 PM ET
    $BMI
    Industrial Machinery/Components
    Industrials

    $AHG
    $ALPP
    $BCEL
    $BEAM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Minerals Technologies Inc. Announces Participation at Upcoming Investor Conferences

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE:MTX) ("MTI") today announced its participation in the following investor conferences: March 3, 2026: J.P. Morgan Global Leveraged Finance Conference in Miami, FL – Douglas T. Dietrich, Chairman and Chief Executive Officer, will present at 11:00 a.m. Eastern Time (ET)March 5, 2026: NYSE Investor Access Series – Materials virtual conferenceMarch 17, 2026: J.P. Morgan Industrials Conference in Washington, DC – Erik Aldag, Chief Financial Officer, will present at 5:00 p.m. ETMarch 19, 2026: Gabelli Funds Annual Specialty Chemicals Symposium in New York, NY MTI will be represented by Douglas T. Dietrich, Chairman and

    2/27/26 2:43:02 PM ET
    $MTX
    Major Chemicals
    Basic Materials

    Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength

    DENVER, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Markets reward momentum and trends may sustain when execution follows headlines. Several companies are now moving beyond announcements and into operational validation, positioning themselves for potential continued follow-through. From biomaterials scale-up to enterprise AI deployment and disciplined capital allocation, these names are building narratives that extend beyond a single news cycle. Kraig Biocraft Laboratories: From Strategy to Scale Activity has accelerated at Kraig Biocraft Laboratories (OTCQB:KBLB) following confirmation that its 2026 production plan has officially transitioned from roadmap to execution. The company has moved bio

    2/27/26 9:45:46 AM ET
    $ENSC
    $PLTR
    $RXT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    $AHG
    $ALPP
    $BCEL
    $BEAM
    Financials

    Live finance-specific insights

    View All

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    NuScale Power Reports Fourth Quarter and Full Year 2025 Results

    NuScale's exclusive global strategic partner, ENTRA1 Energy ("ENTRA1"), and Tennessee Valley Authority ("TVA") continue to advance the largest nuclear power deployment program in U.S. history NuScale completes work on Fluor's Phase 2 Front-End Engineering and Design ("FEED") study for the RoPower Doicești, Romania power plant Study shows NuScale Power technology can support profitable, reliable power for chemical plants, validating exciting NuScale use case NuScale further strengthens cash position through capital market activities NuScale Power Corporation (NYSE:SMR) ("NuScale", "NuScale Power" or the "Company"), the industry-leading provider of proprietary and innovative a

    2/26/26 4:15:00 PM ET
    $SMR
    Metal Fabrications
    Industrials

    Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)

    New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for BEAM‑304 Anticipated in 2026 Updated Phase 1/2 Data and Next Steps for Pivotal Development for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) on Track for Q1 2026 Strategic Financing Agreement with Sixth Street Provides up to $500 Million in Long-term, Non-dilutive Capital to Fund Anticipated Launch of Risto-cel in Sickle Cell Disease (SCD); U.S. Biologics License Application (BLA) Submission Expected as Early as Year-End 2026 Expected Cash Runway Now into Mid-2029 Through Execution of Key Clinical, Regulatory and Commercial Milestones Beam to Host

    2/24/26 7:01:00 AM ET
    $BEAM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHG
    $ALPP
    $BCEL
    $BEAM
    Leadership Updates

    Live Leadership Updates

    View All

    Spectral AI Names Vincent S. Capone as Chief Executive Officer

    DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the Company's Board of Directors has appointed Vincent S. Capone as Chief Executive Officer of the Company, effective February 9, 2026. The appointment of Mr. Capone, who currently serves as the Company's Chief Financial Officer and General Counsel, comes as Spectral AI transitions towards commercialization of its proprietary, non-invasive, AI-driven burn wound assessment device – the DeepView® System. "Vince brings a unique set

    2/10/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    NodThera Appoints Geoff McDonough, M.D., as Chief Executive Officer

    Dr. McDonough brings global company-building, commercial strategy, and R&D leadership experience to the Company ahead of key clinical milestones NodThera plans to report results from two Phase 2 cardiometabolic trials RESOLVE-1 and RESOLVE-2 in mid-2026 and third quarter 2026 respectively Company preparing to begin cardiometabolic Phase 3 trial in 1H 2027 BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- NodThera, the leading clinical-stage NLRP3 company developing a portfolio of best-in-class brain-penetrant and immune-targeted oral inhibitors to address unmet needs in cardiometabolic and neuroinflammatory diseases driven by the NLRP3/IL-6/IL-1 inflammation pathway, announced the appointment o

    2/4/26 8:00:00 AM ET
    $GBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs

    Experienced industry leader brings extensive expertise in leading breakthrough therapies through clinical development to marketing approval Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced the appointment of Antoinette Paone as Chief Development Officer ("CDO") and Head of Regulatory Affairs. Ms. Paone brings extensive experience leading regulatory strategy from clinical development through approval, including her work on Kalydeco and Orkambi at Vertex Pharmaceuticals (NASDAQ:VRTX). She joins Satellos from Generation Bio (NASDAQ:G

    1/29/26 7:00:00 AM ET
    $GBIO
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHG
    $ALPP
    $BCEL
    $BEAM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Generation Bio Co.

    SC 13G/A - Generation Bio Co. (0001733294) (Subject)

    12/9/24 6:18:02 PM ET
    $GBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by NuScale Power Corporation

    SC 13D/A - NUSCALE POWER Corp (0001822966) (Subject)

    11/27/24 7:35:05 AM ET
    $SMR
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13D/A filed by Summit Materials Inc.

    SC 13D/A - Summit Materials, Inc. (0001621563) (Subject)

    11/25/24 9:19:55 AM ET
    $SUM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials